An aspirin that is “thousands of times more powerful” than traditional forms of the drug but has no gastrointestinal side effects looks promising in animal studies, researchers say.The drug, called nitric oxide-donating aspirin, or nitroaspirin, appears to help prevent colon cancer in mice without raising the incidence of gastrointestinal bleeding, researchers reported Oct. 19 at the American Association for Cancer Research meeting in Seattle.
